xanthinol niacinate has been researched along with clofibrate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zicot, M | 1 |
| Reuter, W | 1 |
| Farkas, K; Kusztos, D; Németh-Csóka, M; Pados, G; Valyon, M | 1 |
| Djaja, S; Machalke, K; Richter, E | 1 |
| Ditschuneit, H; Hutt, V; Klör, HU; Wechsler, JG | 2 |
| Audikovski, M; Dem'ianova, N; Kustosh, D; Padosh, D; Puchok, I | 1 |
1 review(s) available for xanthinol niacinate and clofibrate
| Article | Year |
|---|---|
[is there a treatment for peripheral arterial insufficiency?].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clofibrate; Dipyridamole; Fibrinolytic Agents; Humans; Pentoxifylline; Snake Venoms; Xanthinol Niacinate | 1979 |
1 trial(s) available for xanthinol niacinate and clofibrate
| Article | Year |
|---|---|
[Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias].
Topics: Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Theophylline; Xanthinol Niacinate | 1982 |
5 other study(ies) available for xanthinol niacinate and clofibrate
| Article | Year |
|---|---|
[Effects of various modes of therapy on the fatty acid spectrum in hyperlipoproteinemia].
Topics: Cholesterol; Clofibrate; Fatty Acids; Humans; Hyperlipidemias; Nicotinyl Alcohol; Triglycerides; Xanthinol Niacinate | 1977 |
Favourable effect of combined Miscleron-Xavin treatment on HDL-cholesterol level.
Topics: Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Drug Therapy, Combination; Humans; Hyperlipoproteinemias; Theophylline; Triglycerides; Xanthinol Niacinate | 1983 |
Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
Topics: Adolescent; Bezafibrate; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type II; Inositol; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Nicotinic Acids; Nicotinyl Alcohol; Xanthinol Niacinate | 1980 |
[Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
Topics: Biguanides; Cholesterol; Cholesterol, HDL; Clofibrate; Dietary Fats; Humans; Hyperlipoproteinemias; Lipoproteins, HDL; Lipoproteins, LDL; Triglycerides; Xanthinol Niacinate | 1981 |
Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Inositol; Lipoproteins; Nicotinic Acids; Xanthinol Niacinate | 1980 |